Insights on Pharmaceuticals & Medical Products

Article - McKinsey Global Institute

How prioritizing health is a prescription for US prosperity

– As the United States rebuilds its economy in the wake of the pandemic, investing in health can lead the way.
Interview

Recalculating the future of drug development with quantum computing

– Two experts discuss how quantum computing can help solve intractable problems in drug discovery and development.
Article

Winter is coming: What’s next in COVID-19 testing

– The upcoming flu season in the Northern Hemisphere is expected to increase demand for COVID-19 testing. Decision makers may ask:... Will there be enough flexible testing capacity to respond to global demand and avoid second lockdowns?
Article

An optimistic scenario for the US response to COVID-19

– Much would need to happen, but returning the country to something that approaches stability by next summer may be possible.
Article

The European path to reimbursement for digital health solutions

– The “fail fast and break things” approach that tech start-ups favor probably won’t work in healthcare. A slower,... more deliberate route to market and reimbursement is required.
Article

A new prescription for M&A in pharma

– Adopting a through-cycle approach to deal making in the wake of the COVID-19 pandemic can position pharmaceutical companies for... greater success in the next normal.
Survey

The need for speed in the post-COVID-19 era—and how to achieve it

– Survey findings confirm that organizational speed is an essential ingredient for outperformance in times of unprecedented change,... and point to three ways companies can gain speed for the longer term.
Article

Delivering innovation: 2020 oncology market outlook

– At the dawn of a new decade, we take stock of advances and unmet needs in the oncology pharmaceutical market. What will it take... to deliver innovation to patients over the next ten years?
Interview

GSK’s Brian McNamara on the business impact of COVID-19

– The CEO of GlaxoSmithKline Consumer Healthcare discusses the global challenges and possibilities of the next normal and the shifts... now underway in consumer behavior.

Special collections

Collection

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how we treat and potentially cure certain diseases. This collection of articles provides an in-depth look at the opportunities and challenges ahead and the implications for stakeholders in this fast-evolving field. Contact us to learn more.

Collection

The Rise of Health Technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

Executive Briefing

COVID-19: Implications for business

– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.
Interview

An interview with Vyaire Medical CEO Gaurav Agarwal

– “What I love about medical devices is this enormous capability to deliver a better way of healthcare to so many people across... the world.”
Article

Reimagining how life sciences work will be done in the next normal

– The coronavirus pandemic has forced many changes in how life sciences work is done. It may be a misconception that this is the... next normal.
Interview

Medtech innovation in the time of COVID-19: Resilience and growth during a crisis

– COVID-19 is a threat but also a call to action for organizations improving the delivery of healthcare services. Executives from... four leading medtech firms share how they have thrived during this crisis by applying their business-building capabilities.
Article

Improving the fragile US supply of blood

– For a system that relies on the altruism of contributors, an aging class of donors and changing attitudes put the nation’s... blood supply at risk.
Article

Medtech’s call to action: Meeting the demand surge caused by COVID-19

– Five interventions have helped manufacturers ease supply constraints for medtech products during the pandemic. Important lessons... have been learned along the way.
Article

Managing China’s growing oncology burden

– Significant increases in incidence rates have made cancer a high priority in China. Progress has resulted from innovative treatments... and greater access to care, yet much more needs to be done.
Article

COVID-19 exposes a critical shortage of oxygen in developing countries

– The COVID-19 crisis is exacerbating what is considered a critical vulnerability in the health infrastructure of many developing... countries—a severe shortage of medical oxygen.
Article

COVID-19 and cell and gene therapy: How to keep innovation on track

– Cell and gene therapies promise life-changing treatments, but the pandemic has hit the sector hard. A survey reveals the extent... of the disruption and suggests actions to help companies become more resilient.
Article

Ten battlegrounds for digital and analytics in life sciences

– Life-sciences companies have yet to realize the full potential of digital and analytics. Pioneers are finding success by focusing... on entire parts of the business system rather than use case projects.
Article

Automation and the future of work in the US biopharma industry

– The US biopharma industry has been slower than some others to embrace enterprise-wide automation. As it accelerates adoption,... it will radically alter the future of work for its employees.
Sorry, we couldn't find any results. Try removing some filters.

More from this practice

McKinsey Cancer Center

The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.

Connect with our Pharmaceuticals & Medical Products Practice